Navigation Links
InfoSpi Shall Benefit From Contract for Future Use of IBS Technology
Date:2/5/2010

FT. LAUDERDALE, Fla., Feb. 5 /PRNewswire-FirstCall/ -- InfoSpi Inc. (OTC Bulletin Board: ISPI) announced today an important development within the process of the negotiations to acquire the business and advanced technology of Integral Bioenergies Systems, SL (IBS). This firm has developed and protected a proprietary technology process that allows the treatment of biomass/sludge obtained at sewage treatment plants.

IBS has entered into a contract with Tedagua (www.tedagua.com), a member of the ACS Group (www.acscorporate.com). Tedagua is a worldwide leader in the industry of water treatment plants operating projects in many cities of Mexico, Central and South America, Africa, China and the Middle East.

Onildo Mersing Huusmann, President and CEO of IBS, said, "This contract will allow the future use of IBS's technology in the processing and treatment of biomass/sludge obtained at sewage/water-treatment plants."

Chris Hamilton, CEO of InfoSpi states that this contract shall afford a great opportunity for InfoSpi in the development of its plans.

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of InfoSpi Inc. and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

www.infospiinc.com

SOURCE InfoSpi Inc.

RELATED LINKS
http://www.infospiinc.com

'/>"/>

SOURCE InfoSpi Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market
2. Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
3. John Marshall and Kevin McGuinness Appointed to Ellex Board
4. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
5. Adaptive Trial Paper Explores Benefits of Adaptive Trials for Phase I, Phase II Studies
6. Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer
7. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
8. Commercial Insurance Buyers Benefit From Ample Capacity
9. TriLink BioTechnologies to Sponsor GIVING HUNGER THE BLUES, a Benefit Concert to Help Alleviate Hunger in San Diego County
10. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
11. LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 2, 2016 CytRx Corporation (NASDAQ: ... in oncology, today announced the appointment of Earl ... consultant, and private healthcare investor, to its Board of ... with clinical and strategic experience at the highest level," ... CEO. "As one of the world,s leading orthopedic surgeons, ...
(Date:12/2/2016)... ... December 01, 2016 , ... Aerocom Healthcare ( ... hospitals, will present its chain-of-custody solution for tracking and securing medications at booth ... Dec. 4-8, 2016. , Aerocom has a proven solution for tracking medications via ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... Nanowear on their recent FDA Class II 510(k) clearance for their flagship medical ... in commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. While other ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected ... of 7.3% during the forecast period of 2016 to 2021 dominated ... accounted for the largest share of immunohistochemistry (IHC) market, by end ... , , ... market spread across 225 pages, profiling 10 companies and supported with ...
Breaking Biology Technology:
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
Breaking Biology News(10 mins):